A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
We're making World Mental Health Day by sharing some tips on managing your mental health from a person with Parkinson's and a Parkinson's nurse
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Parkinson’s UK Scotland is delighted that it has been able to appoint ten outstanding candidates to a new advisory group that will be at the heart of shaping the charity’s work in Scotland.
Information about our latest campaign to improve care for people with Parkinson's in hospital and a request for people to sign our petition
Together, we’ve been working on our 2020 to 2024 strategy. Scaling up our previous successes, it’s more ambitious than ever. Because you’ve told us it has to be.
A new guide has been launched to help charities support patients to have their say on research carried out by the pharmaceutical industry.
Update to ensure people with Parkinson's and family members is prepared for Brexit
This event, for anyone with an interest in Parkinson’s research, will take place on Saturday 23 November at the Cranmore Park Conference & Events Centre, outside Birmingham.
Our Members' Day and Annual General Meeting (AGM) is just around the corner. Here are 5 things to watch out for.